Evidence map›Paper›PMID 30918369›Full record

ReviewNature reviews. Genetics2019

Clinical metagenomics.

Charles Y Chiu, Steven A Miller

4 registry-linked trialsAbstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 961 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
961citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06157372 unknown statusnot on this mapstarted 2023, after this paper: background citation

Detection of Pathogen and Antibiotic Resistance Genes by Targeted Next-Generation Sequencing Compared With Metagenomic Next-Generation Sequencing in ICU Patients.

TypeobservationalSponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRan2023 to 2024Enrolled20ConditionsInfections, Critical Illness, DiagnosisArmstargeted next-generation sequencing (tNGS)
NCT06566898 recruitingnot on this mapstarted 2024, after this paper: background citation

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients: a Genomic Epidemiology Study

TypeobservationalSponsorShanghai General Hospital, ChinaRan2024 to 2026Enrolled800ConditionsPneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
NCT06775808 recruitingnot on this mapstarted 2024, after this paper: background citation

Total Infectome Characterization of Eye Infections: a Metagenomic Sequencing Based Observational Study

TypeobservationalSponsorShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRan2024 to 2026Enrolled200ConditionsEye Infections, Diagnosis
NCT07626073 enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

h Can Provide the Detection Results of Pathogen Type and Resistant Gene. This Study is a Prospective Multi Centers Study to Explore Using the New Diagnostic Tool of " RPIP " and the Different Detection Methods of Next Generation Sequencing and Multiplex PC R in Patients With Pneumonia in ICU. Further Compare the Difference of Pathogen Identification and Clinical Impact by Different Diagnostic Methods.

Typeobservational_patient_registrySponsorChina Medical University HospitalRan2023 to 2028Enrolled200ConditionsRespiratory Pathogens
3 · Its place in the literature

Who cites it

961 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Analysis of bacteriophage diversity in Ganga river ecosystem: insights from metagenome-based sequencing.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  5. First case of neonatal bloodstream infection caused byExperimental and therapeutic medicine · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Detection ofASM case reports · 2026
    Article
  18. Article
  19. Article
  20. Review

901 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Charles Y ChiuDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA. charles.chiu@ucsf.edu.ORCID http://orcid.org/0000-0003-2915-2094
Steven A MillerDepartment of Laboratory Medicine, University of California, San Francisco, CA, USA.

Funding

Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious AgentsR01HL105704 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2011 to 2020
$5.9M
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore SequencingR33AI120977 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIU, CHARLES YEN · 2018 to 2020
$1.6M
NHLBI NIH HHS R01 HL105704NIAID NIH HHS R33 AI120977
6 · The paper itself

Abstract

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host genetic material (DNA and RNA) in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing how physicians diagnose and treat infectious disease, with applications spanning a wide range of areas, including antimicrobial resistance, the microbiome, human host gene expression (transcriptomics) and oncology. Here, we focus on the challenges of implementing mNGS in the clinical laboratory and address potential solutions for maximizing its impact on patient care and public health.

Indexed as

MetagenomeAnimalsAnti-Bacterial AgentsBacteriaCommunicable DiseasesDNADrug Resistance, Multiple, BacterialFungiHelminthsHigh-Throughput Nucleotide SequencingHost-Pathogen InteractionsHumansMedical Laboratory ScienceMetagenomicsPublic HealthVirusesAnti-Bacterial AgentsDNA

Identifiers

PMID30918369
PMCPMC6858796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.